Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Apotea AB is a leading online pharmacy in Sweden, specializing in the distribution of prescription and over-the-counter medications. The company's competitive position is bolstered by its extensive logistics network and strong brand recognition, allowing it to capture a significant share of the growing e-pharmacy market in the Nordic region.
Apotea generates revenue primarily through online sales of pharmaceuticals and health products, leveraging its efficient logistics and distribution systems to maintain competitive pricing. The company benefits from a strong customer loyalty program and a user-friendly platform that enhances customer experience and retention.
Changes in e-pharmacy regulations in Sweden and the EU
Growth in online healthcare spending among consumers
Expansion of product offerings and partnerships with pharmaceutical companies
Seasonal demand fluctuations for health products
Regulatory changes affecting e-pharmacy operations
Technological disruption in logistics and delivery systems
Increased competition from other online pharmacies and traditional retailers entering the e-pharmacy space
Potential market share loss to larger global players
Low liquidity due to high inventory levels
Potential impact of currency fluctuations on imported goods
moderate - Apotea's performance is somewhat linked to consumer spending and healthcare expenditure, which can be influenced by economic cycles.
Interest rates affect Apotea's financing costs for inventory and logistics investments. Higher rates may compress margins if borrowing costs rise significantly.
minimal - The company operates with a low debt-to-equity ratio, reducing its reliance on credit markets.
growth - Investors are likely attracted to Apotea for its strong revenue growth potential in the expanding e-pharmacy market.
moderate - The stock has shown moderate volatility, reflective of its growth stage and market dynamics.
